The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125618491 12561849 1 I 20160706 20160715 20160715 EXP US-SA-2016SA126296 AVENTIS SIVARAJ D, GREEN M M, CIFTCI A M, ZAHID M F, JOHNS A A, ROSS M ET AL. CAN WE CURE LIGHT CHAIN DEPOSITION DISEASE OF THE KIDNEYS? A REVIEW AND CASE REPORT OF A PATIENT TREATED WITH A TRIPLE TRANSPLANT APPROACH. CLINICAL LYMPHOMA, MYELOMA + LEUKEMIA. 2016 JUN; 16(6):95-100. DOI: 10.1016/J.CLML.2016.03.002 43.00 YR A F Y 0.00000 20160715 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125618491 12561849 1 PS ALEMTUZUMAB ALEMTUZUMAB 1 Intravenous (not otherwise specified) UNKNOWN 103948 20 MG QD
125618491 12561849 2 SS FLUDARABINE PHOSPHATE. FLUDARABINE PHOSPHATE 1 Unknown UNKNOWN 20038 30 MG/M**2 QD
125618491 12561849 3 SS FLUDARABINE PHOSPHATE. FLUDARABINE PHOSPHATE 1 Intravenous (not otherwise specified) UNKNOWN 20038 25 MG/M**2 QD
125618491 12561849 4 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) UNKNOWN 0 950 MG QD
125618491 12561849 5 SS DEXAMETHASONE. DEXAMETHASONE 1 Unknown Y UNKNOWN 0
125618491 12561849 6 SS PREDNISONE. PREDNISONE 1 Unknown Y U UNKNOWN 0
125618491 12561849 7 SS PREDNISONE. PREDNISONE 1 Unknown Y U UNKNOWN 0
125618491 12561849 8 SS THALIDOMIDE THALIDOMIDE 1 Unknown Y UNKNOWN 0
125618491 12561849 9 C MELPHALAN MELPHALAN 1 0
125618491 12561849 10 C MELPHALAN MELPHALAN 1 Intravenous (not otherwise specified) 0 70 MG/M**2 QD
125618491 12561849 11 C CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0
125618491 12561849 12 C FK 506 TACROLIMUS 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125618491 12561849 1 Bone marrow conditioning regimen
125618491 12561849 2 Bone marrow conditioning regimen
125618491 12561849 3 Bone marrow conditioning regimen
125618491 12561849 4 Bone marrow conditioning regimen
125618491 12561849 5 Immune tolerance induction
125618491 12561849 6 Immunomodulatory therapy
125618491 12561849 7 Immunomodulatory therapy
125618491 12561849 8 Immune tolerance induction
125618491 12561849 9 Chemotherapy
125618491 12561849 10 Chemotherapy
125618491 12561849 11 Immunomodulatory therapy
125618491 12561849 12 Immunomodulatory therapy

Outcome of event

Event ID CASEID OUTC COD
125618491 12561849 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125618491 12561849 Cytomegalovirus infection
125618491 12561849 Fluid overload
125618491 12561849 Graft versus host disease
125618491 12561849 Off label use
125618491 12561849 Renal failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125618491 12561849 1 200612 200612 0
125618491 12561849 2 200612 200612 0
125618491 12561849 3 2007 2007 0
125618491 12561849 4 200612 200612 0
125618491 12561849 10 2007 2007 0